Hyperimmune anti-COVID-19 IVIG (C-IVIG) Therapy for Passive Immunization of Severe and Critically Ill COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial.

ABSTRACT:

SUBMITTER: Ali S 

PROVIDER: S-EPMC7604645 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature